Latest news
News
-
18 April 2019
Our 2018 Achievements Published
Take a look over our achievements from the last 12 months.
-
17 April 2019
Cimzia & Ilumetri - NICE Approves Two New Biologic Treatments for Psoriasis
The injectable treatments, Cimzia (Certolizumab Pegol) and Ilumetri (Tildrakizumab), get the go ahead from NICE.
-
16 April 2019
Prescription Charges in England Rise Again
Remember that a three month prescription prepayment certificate is available for £29.10, and a twelve month certificate for £104.
-
12 April 2019
Latest Research Grants Announced
This year we've awarded two new PhD Studentships as well as the Cecil King Memorial Award and one Small Grant.
-
8 April 2019
Cimzia (Certolizumab Pegol) - New Biologic Approved for Psoriasis in Scotland
The SMC approves Cimzia (Certolizumab Pegol) for the treatment of psoriasis in adults in Scotland.